Tissue‐Agnostic Cellular Morphometric Biomarkers for Risk‐Adapted Management Across Gastrointestinal Precancerous Lesions and Cancers
ABSTRACT While precision oncology increasingly adopts tissue‐agnostic paradigms, current strategies remain heavily reliant on molecular alterations, with limited relevance to early‐stage cancers and precancerous lesion management. Here we present an unsupervised and interpretable artificial intelligence framework that...